European Stocks Trim Best Month Since 2015 as Banks Fall on ECB
(Bloomberg) -- European equities pared the best monthly advance since 2015 after investors were disappointed by the European Central Bank's policy update, with banks leading the slump.
The Stoxx Europe 600 Index dropped 2%. Cyclicals including banks and miners were among the worst performers, while a historic dividend cut from Royal Dutch Shell Plc also dragged down energy shares.
The ECB today maintained its pandemic emergency purchase program, while cutting the cost of funding for lenders and refraining from boosting its bond-buying plan. Despite today's downturn, European equities gained 6.2% in April amid stimulus measures and optimism about the rate of coronavirus infections easing, paving the way for countries to lift lockdowns.
“Markets have been left disappointed by the ECB's failure to boost bond purchases, instead hiding behind a very long press release that only announced two small adjustments, both focused on cheaper loans to banks,” said Seema Shah, chief strategist at Principal Global Investors. “Essentially, the ECB's chosen strategy seems to be sweetening banks in order to convince them to lend into the real economy. If this is the ECB's response to the U.S. Main Street Lending Program, markets' disappointment may be valid.”
The ECB on Thursday urged politicians to provide more fiscal support in response to the pandemic's impact, hours after a report showing a record gross domestic product contraction in the euro area. President Christine Lagarde warned that the economy could shrink as much as 12% this year.
Policy makers reduced the cost of their emergency loan program for banks, and unveiled a further facility to inject liquidity into the economy.
”In the eurozone's worst recession ever, the ECB will almost certainly have to scale up its asset purchases this year,” said Florian Hense, European economist at Berenberg. “The bank had no need to do so today already.”
| Read More on What Stoxx 600 Companies Are Doing in Response to Covid-19 |
| Lysol Flies Off Shelves; Chemical Sales Slump: Earnings Wrap |
| Shell Cuts Payout, Sainsbury Defers Decision: Dividend Tracker |
| The Pandemic's Impact on Europe's General Meetings: AGM Tracker |
| Here's How Virus Upends Forecasts in Europe: Guidance Tracker |
Banks fell the most in more than a week, with Societe Generale SA and Lloyds Banking Group Plc down more than 7% after also reporting results.
Among other notable movers, Reckitt Benckiser Group Plc climbed 3.6% after increasing its full-year outlook as exceptional demand for the company's hygiene and health products drove its strongest start to the year in recent memory.
Investors are also carefully watching for signs of progress in managing the coronavirus. Stocks around the world surged on Wednesday after Gilead Sciences Inc. said its experimental drug helped Covid-19 patients recover faster.
©2020 Bloomberg L.P.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.